Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

66
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
66
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

47
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
47
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

15
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
15
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.4K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

1.3K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.3K
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

94
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
94

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sono-Activated Artificial Vanadium Enzyme System for Efficient and Renewable Reactive Oxygen Nanobiocatalytic Therapies.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Investigation of an Infectious Diarrhea Outbreak Associated with Direct Drinking Water in a High School - Baisha County, Hainan Province, China, November 2024.

China CDC weekly·2026
Same author

Research Progress of Nanodelivery Platforms in the Diagnosis and Treatment of Esophageal Cancer.

International journal of nanomedicine·2026
Same author

The effect of Snyder's hope theory-based psychological intervention on post-traumatic growth in chinese women experiencing perinatal loss: a randomised controlled trial.

Journal of psychosomatic obstetrics and gynaecology·2026
Same author

Pathogen spectrum in the children with foreign body aspiration in southwest China.

BMC pulmonary medicine·2026
Same author

Ultrahigh-Resolution Transfer Patterning of Quantum Dot Light-Emitting Diodes via Soft-Contact Polymer Interface Engineering.

Nano letters·2026

Related Experiment Video

Updated: Apr 19, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.9K

Hydroxamic acids block replication of hepatitis C virus.

Teng Ai1, Yanli Xu, Li Qiu

  • 1Center for Drug Design, Academic Health Center, University of Minnesota , 516 Delaware Street S.E., Minneapolis, Minnesota 55455, United States.

Journal of Medicinal Chemistry
|December 10, 2014
PubMed
Summary

Researchers explored histone deacetylase (HDAC) inhibitors for hepatitis C virus (HCV) replication. Novel hydroxamic acid compounds demonstrated potent and selective anti-HCV activity, offering promising therapeutic starting points.

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

31.0K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 19, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.9K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

31.0K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Area of Science:

  • Biochemistry
  • Virology
  • Medicinal Chemistry

Background:

  • Protein acetylation plays a role in hepatitis C virus (HCV) replication.
  • Histone deacetylase (HDAC) inhibitors are potential therapeutic agents.

Purpose of the Study:

  • To investigate the efficacy of known HDAC inhibitors and novel hydroxamic acids against HCV replication.
  • To identify potent and selective anti-HCV compounds for further development.

Main Methods:

  • Screening of known HDAC inhibitors and a focused library of hydroxamic acids against an HCV subgenomic replicon.
  • Structure-activity relationship (SAR) studies on cinnamic hydroxamic acid and benzo[b]thiophen-2-hydroxamic acid derivatives.

Main Results:

  • Known HDAC inhibitors showed limited efficacy or toxicity.
  • SAR studies identified compounds 22 and 53 with potent and selective anti-HCV activity.
  • These compounds represent promising leads for further optimization.

Conclusions:

  • Novel hydroxamic acid derivatives are effective inhibitors of HCV replication.
  • Compounds 22 and 53 warrant further investigation as potential anti-HCV therapeutics.